Citius Oncology, Inc. Revenue
Citius Oncology, Inc. (CTOR) reported Revenue of $1.49 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-14
- Citius Oncology, Inc. revenues for the quarter ending 2026-06-30 was $1.49M.
- Citius Oncology, Inc. revenues for the quarter ending 2026-03-31 was $1.67M.
- Citius Oncology, Inc. revenues for the quarter ending 2025-12-31 was $3.94M.
| Period end | Revenues 3 month | Revenues 6 month | Revenues 9 month |
|---|---|---|---|
| 2026-06-30 | $1.49M 10-Q · filed 2026-08-14 | $3.16M derived: sum of 2 quarters · filed 2026-08-14 | $7.11M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $1.67M 10-Q · filed 2026-05-15 | $5.61M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $3.94M 10-Q · filed 2026-02-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anixa Biosciences Inc (ANIX) | United States | $0.096B | |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |